Allspring Global Investments Holdings LLC Sells 74,138 Shares of Ralliant Corporation $RAL

Key Points

• Allspring Global Investments cut its stake in Ralliant by 23.4%, selling 74,138 shares in Q4 and ending the period with 242,900 shares worth about $12.44 million.
• Insiders bought stock: SVP Amir A. Kazmi purchased 2,545 shares and Director Kevin E. Bryant bought 1,250 shares, part of insiders acquiring 8,145 shares worth $332,233 over the last quarter.
• Analyst views are mixed with several price-target cuts; the stock has a MarketBeat consensus of Hold and an average price target of $50.50 (7 Buy, 3 Hold, 2 Sell).

Allspring Global Investments Holdings LLC lessened its holdings in Ralliant Corporation (NYSE:RAL - Free Report) by 23.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 242,900 shares of the company's stock after selling 74,138 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.22% of Ralliant worth $12,441,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in the business. Westfuller Advisors LLC purchased a new position in shares of Ralliant in the third quarter worth about $26,000. Palisade Asset Management LLC purchased a new stake in Ralliant during the 3rd quarter valued at about $26,000. UMB Bank n.a. purchased a new stake in Ralliant during the 3rd quarter valued at about $29,000. BOKF NA bought a new position in Ralliant during the 3rd quarter worth approximately $29,000. Finally, Wilmington Savings Fund Society FSB bought a new position in Ralliant during the 3rd quarter worth approximately $30,000.

Insider Buying and Selling

In other news, SVP Amir A. Kazmi purchased 2,545 shares of the company's stock in a transaction that occurred on Friday, February 6th. The shares were bought at an average cost of $39.27 per share, for a total transaction of $99,942.15. Following the completion of the transaction, the senior vice president directly owned 39,699 shares of the company's stock, valued at $1,558,979.73. This trade represents a 6.85% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Kevin E. Bryant purchased 1,250 shares of the firm's stock in a transaction that occurred on Friday, February 6th. The stock was acquired at an average price of $39.97 per share, with a total value of $49,962.50. Following the completion of the purchase, the director owned 4,653 shares in the company, valued at $185,980.41. This represents a 36.73% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought a total of 8,145 shares of company stock worth $332,233 over the last quarter.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Citigroup lowered their price objective on Ralliant from $61.00 to $51.00 and set a "buy" rating for the company in a research report on Friday, February 6th. Zacks Research cut shares of Ralliant from a "hold" rating to a "strong sell" rating in a report on Monday, February 9th. Royal Bank Of Canada decreased their target price on shares of Ralliant from $52.00 to $41.00 and set a "sector perform" rating on the stock in a research note on Friday, February 6th. Truist Financial dropped their target price on shares of Ralliant from $62.00 to $49.00 and set a "buy" rating for the company in a report on Friday, February 6th. Finally, Weiss Ratings cut Ralliant from a "hold (c)" rating to a "sell (d)" rating in a research note on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Ralliant currently has a consensus rating of "Hold" and an average price target of $50.50.

Ralliant Trading Down 0.2%

Shares of RAL opened at $41.92 on Monday. Ralliant Corporation has a 1-year low of $37.27 and a 1-year high of $57.02. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.38. The firm's 50-day moving average price is $44.96 and its 200-day moving average price is $46.72. The firm has a market capitalization of $4.68 billion and a price-to-earnings ratio of 21.39.

Ralliant (NYSE:RAL - Get Free Report) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to the consensus estimate of $543.04 million. Ralliant's quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 23rd. Stockholders of record on Monday, March 9th were given a $0.05 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. Ralliant's dividend payout ratio is currently 10.20%.

Ralliant Company Profile

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.